
Will GoodRX Stock Bounce Back?
GoodRX (NASDAQ:GDRX) tracks prescription drug prices and its model was…
Period Ending | 2020-12-31 | 2021-12-31 | 2022-12-31 | 2023-12-31 | 2024-12-31 | |
---|---|---|---|---|---|---|
Revenue | $614.9M | $1B | $1.4B | $667.5M | $666.8M | |
Revenue Growth (YoY) | -36.69% | 63.3% | 37.15% | -51.53% | -0.11% | |
Cost of Revenues | $590M | $443M | $460.9M | $364.9M | $406.9M | |
Gross Profit | $24.9M | $561.1M | $916.2M | $302.7M | $259.9M | |
Gross Profit Margin | 4.05% | 55.88% | 66.53% | 45.35% | 38.98% | |
R&D Expenses | -- | -- | -- | -- | -- | |
Selling, General & Admin | -$47.1M | -$53.2M | -$52.3M | -$46.3M | -$44.8M | |
Other Inc / (Exp) | -- | -- | -- | -- | -- | |
Operating Expenses | $63.5M | $160.2M | $119.3M | $77.3M | $113.9M | |
Operating Income | -$38.6M | $400.9M | $796.9M | $225.4M | $146M | |
Net Interest Expenses | $125.6M | $95M | $78.3M | $31M | $40.2M | |
EBT. Incl. Unusual Items | -$425.8M | $220.1M | $346.5M | $151.3M | -$13.3M | |
Earnings of Discontinued Ops. | -- | -- | -- | -- | -- | |
Income Tax Expense | -$139.8M | $16.3M | -$38.4M | $132.7M | $13.8M | |
Net Income to Company | -$425.8M | $220.1M | $346.5M | $151.3M | -$13.3M | |
Minority Interest in Earnings | -- | -- | -- | -- | -- | |
Net Income to Common Excl Extra Items | -$285.9M | $203.9M | $384.9M | $18.6M | -$27.1M | |
Basic EPS (Cont. Ops) | -$0.29 | $0.21 | $0.39 | $0.02 | -$0.03 | |
Diluted EPS (Cont. Ops) | -$0.29 | $0.21 | $0.39 | $0.02 | -$0.03 | |
Weighted Average Basic Share | $975.7M | $975.4M | $987M | $980M | $975M | |
Weighted Average Diluted Share | $975.7M | $975.4M | $987M | $980M | $975M | |
EBITDA | $22.9M | $500.3M | $636.2M | $359.7M | $241.4M | |
EBIT | -$338.5M | $294.3M | $419.5M | $213.3M | $57.3M | |
Revenue (Reported) | $614.9M | $1B | $1.4B | $667.5M | $666.8M | |
Operating Income (Reported) | -$38.6M | $400.9M | $796.9M | $225.4M | $146M | |
Operating Income (Adjusted) | -$338.5M | $294.3M | $419.5M | $213.3M | $57.3M |
Period Ending | 2021-03-31 | 2022-03-31 | 2023-03-31 | 2024-03-31 | 2025-03-31 | |
---|---|---|---|---|---|---|
Revenue | $169.7M | $339.5M | $269M | $182.6M | $187.6M | |
Revenue Growth (YoY) | -17.46% | 100.06% | -20.77% | -32.12% | 2.74% | |
Cost of Revenues | $85.8M | $95M | $104.7M | $107.5M | $121.1M | |
Gross Profit | $83.9M | $244.5M | $164.3M | $75.2M | $66.5M | |
Gross Profit Margin | 49.44% | 72.02% | 61.08% | 41.18% | 35.45% | |
R&D Expenses | -- | -- | -- | -- | -- | |
Selling, General & Admin | $5.5M | $2.6M | $4.2M | $6.1M | $11.1M | |
Other Inc / (Exp) | -- | -- | -- | -- | -- | |
Operating Expenses | $17.7M | $8.2M | $10.9M | $14.3M | $42.1M | |
Operating Income | $66.2M | $236.3M | $153.4M | $60.9M | $24.4M | |
Net Interest Expenses | $19.8M | $28.9M | -- | $8.8M | $15.9M | |
EBT. Incl. Unusual Items | $46.5M | $207.4M | $158.2M | $59.3M | $15.7M | |
Earnings of Discontinued Ops. | -- | -- | -- | -- | -- | |
Income Tax Expense | -$5M | $66.9M | $70.8M | $42.5M | $19.3M | |
Net Income to Company | $46.5M | $207.4M | $158.2M | $59.3M | $15.7M | |
Minority Interest in Earnings | -- | -- | -- | -- | -- | |
Net Income to Common Excl Extra Items | $51.5M | $140.5M | $87.4M | $16.8M | -$3.6M | |
Basic EPS (Cont. Ops) | $0.05 | $0.14 | $0.09 | $0.02 | -- | |
Diluted EPS (Cont. Ops) | $0.05 | $0.14 | $0.09 | $0.02 | -- | |
Weighted Average Basic Share | $975.4M | $975.4M | $995.5M | $975M | $975M | |
Weighted Average Diluted Share | $975.4M | $975.4M | $995.5M | $975M | $975M | |
EBITDA | $127.1M | $288M | $220.3M | $123M | $90.8M | |
EBIT | $74.1M | $236.5M | $175.7M | $73.2M | $39.7M | |
Revenue (Reported) | $169.7M | $339.5M | $269M | $182.6M | $187.6M | |
Operating Income (Reported) | $66.2M | $236.3M | $153.4M | $60.9M | $24.4M | |
Operating Income (Adjusted) | $74.1M | $236.5M | $175.7M | $73.2M | $39.7M |
Period Ending | 2021-03-31 | 2022-03-31 | 2023-03-31 | 2024-03-31 | 2025-03-31 | |
---|---|---|---|---|---|---|
Revenue | $578.9M | $1.2B | $1.3B | $581.2M | $671.7M | |
Revenue Growth (YoY) | -- | -- | -- | -- | -- | |
Cost of Revenues | $508.6M | $452.3M | $470.7M | $367.5M | $420.6M | |
Gross Profit | $70.3M | $721.5M | $835.9M | $213.8M | $251.1M | |
Gross Profit Margin | -- | -- | -- | -- | -- | |
R&D Expenses | -- | -- | -- | -- | -- | |
Selling, General & Admin | -$37M | -$56M | -$50.7M | $25.2M | $28.5M | |
Other Inc / (Exp) | -- | -- | -- | -- | -- | |
Operating Expenses | $70.3M | $150.9M | $122M | $80.7M | $141.9M | |
Operating Income | -- | $570.6M | $713.9M | $133.1M | $109.2M | |
Net Interest Expenses | $106.9M | $104.1M | $46.5M | $78.8M | $34M | |
EBT. Incl. Unusual Items | -$329.2M | $381.1M | $297.4M | $52.3M | -$57M | |
Earnings of Discontinued Ops. | -- | -- | -- | -- | -- | |
Income Tax Expense | -$134.2M | $88.2M | -$34.5M | $104.3M | -$9.4M | |
Net Income to Company | -$329.2M | $381M | $297.3M | $52.4M | -$56.9M | |
Minority Interest in Earnings | -- | -- | -- | -- | -- | |
Net Income to Common Excl Extra Items | -$194.9M | $293M | $331.8M | -$52M | -$47.5M | |
Basic EPS (Cont. Ops) | -$0.21 | $0.30 | $0.33 | -$0.06 | -$0.04 | |
Diluted EPS (Cont. Ops) | -$0.21 | $0.30 | $0.33 | -$0.06 | -$0.04 | |
Weighted Average Basic Share | ||||||
Weighted Average Diluted Share | ||||||
EBITDA | $55.2M | $661.4M | $568.6M | $312.4M | $203.2M | |
EBIT | -$251.7M | $456.8M | $358.8M | $160.8M | $17.7M | |
Revenue (Reported) | $578.9M | $1.2B | $1.3B | $581.2M | $671.7M | |
Operating Income (Reported) | -- | $570.6M | $713.9M | $133.1M | $109.2M | |
Operating Income (Adjusted) | -$251.7M | $456.8M | $358.8M | $160.8M | $17.7M |
Period Ending | 2021-03-31 | 2022-03-31 | 2023-03-31 | 2024-03-31 | 2025-03-31 | |
---|---|---|---|---|---|---|
Revenue | $169.7M | $339.5M | $269M | $182.6M | $187.6M | |
Revenue Growth (YoY) | -- | -- | -- | -- | -- | |
Cost of Revenues | $85.8M | $95M | $104.7M | $107.5M | $121.1M | |
Gross Profit | $83.9M | $244.5M | $164.3M | $75.2M | $66.5M | |
Gross Profit Margin | -- | -- | -- | -- | -- | |
R&D Expenses | -- | -- | -- | -- | -- | |
Selling, General & Admin | $5.5M | $2.6M | $4.2M | $6.1M | $11.1M | |
Other Inc / (Exp) | -- | -- | -- | -- | -- | |
Operating Expenses | $17.7M | $8.2M | $10.9M | $14.3M | $42.1M | |
Operating Income | $66.2M | $236.3M | $153.4M | $60.9M | $24.4M | |
Net Interest Expenses | $19.8M | $28.9M | -- | $8.8M | $15.9M | |
EBT. Incl. Unusual Items | $46.5M | $207.4M | $158.2M | $59.3M | $15.7M | |
Earnings of Discontinued Ops. | -- | -- | -- | -- | -- | |
Income Tax Expense | -$5M | $66.9M | $70.8M | $42.5M | $19.3M | |
Net Income to Company | $46.5M | $207.4M | $158.2M | $59.3M | $15.7M | |
Minority Interest in Earnings | -- | -- | -- | -- | -- | |
Net Income to Common Excl Extra Items | $51.5M | $140.5M | $87.4M | $16.8M | -$3.6M | |
Basic EPS (Cont. Ops) | $0.05 | $0.14 | $0.09 | $0.02 | -- | |
Diluted EPS (Cont. Ops) | $0.05 | $0.14 | $0.09 | $0.02 | -- | |
Weighted Average Basic Share | $975.4M | $975.4M | $995.5M | $975M | $975M | |
Weighted Average Diluted Share | $975.4M | $975.4M | $995.5M | $975M | $975M | |
EBITDA | $127.1M | $288M | $220.3M | $123M | $90.8M | |
EBIT | $74.1M | $236.5M | $175.7M | $73.2M | $39.7M | |
Revenue (Reported) | $169.7M | $339.5M | $269M | $182.6M | $187.6M | |
Operating Income (Reported) | $66.2M | $236.3M | $153.4M | $60.9M | $24.4M | |
Operating Income (Adjusted) | $74.1M | $236.5M | $175.7M | $73.2M | $39.7M |
Period Ending | 2020-12-31 | 2021-12-31 | 2022-12-31 | 2023-12-31 | 2024-12-31 | |
---|---|---|---|---|---|---|
Cash and Equivalents | $463.5M | $720.8M | $931.8M | $704.5M | $881.5M | |
Short Term Investments | -- | -- | -- | -- | -- | |
Accounts Receivable, Net | $123.6M | $361.6M | $325.8M | $161.6M | $192.1M | |
Inventory | $41.9M | $35.8M | $47M | $77.8M | $74.8M | |
Prepaid Expenses | -- | -- | -- | -- | -- | |
Other Current Assets | -- | -- | -- | -- | -- | |
Total Current Assets | $821.6M | $1.3B | $1.5B | $1.1B | $1.3B | |
Property Plant And Equipment | $1.5B | $1.5B | $1.2B | $1.3B | $1.3B | |
Long-Term Investments | -- | -- | -- | -- | -- | |
Goodwill | $162M | $88.2M | $56.1M | $43.2M | $102.1M | |
Other Intangibles | $27.8M | $25.3M | $22.4M | $20.9M | $18.5M | |
Other Long-Term Assets | -$100K | $100K | -$100K | $100K | $200K | |
Total Assets | $2.7B | $2.9B | $2.8B | $2.6B | $3B | |
Accounts Payable | $64.7M | $103M | $71.7M | $71.7M | $188.2M | |
Accrued Expenses | -- | -- | -- | -- | -- | |
Current Portion Of Long-Term Debt | -- | -- | -- | -- | -- | |
Current Portion Of Capital Lease Obligations | $3.8M | -- | $6.8M | $3.6M | $3.1M | |
Other Current Liabilities | -- | -- | -- | -- | -- | |
Total Current Liabilities | $296.2M | $385.8M | $445.3M | $415.3M | $353.9M | |
Long-Term Debt | $934.2M | $873.4M | $546.5M | $392M | $790.5M | |
Capital Leases | -- | -- | -- | -- | -- | |
Total Liabilities | $1.9B | $1.9B | $1.4B | $1.4B | $1.9B | |
Common Stock | $32.9M | $32.9M | $33.9M | $32.9M | $32.9M | |
Other Common Equity Adj | -- | -- | -- | -- | -- | |
Common Equity | $845.6M | $1B | $1.4B | $1.2B | $1.1B | |
Total Preferred Equity | -- | -- | -- | -- | -- | |
Minority Interest, Total | -- | -- | -- | -- | -- | |
Total Equity | $845.6M | $1B | $1.4B | $1.2B | $1.1B | |
Total Liabilities and Equity | $2.7B | $2.9B | $2.8B | $2.6B | $3B | |
Cash and Short Terms | $463.5M | $720.8M | $931.8M | $704.5M | $881.5M | |
Total Debt | $934.2M | $873.4M | $554.9M | $558.2M | $790.5M |
Period Ending | 2021-03-31 | 2022-03-31 | 2023-03-31 | 2024-03-31 | 2025-03-31 | |
---|---|---|---|---|---|---|
Cash and Equivalents | $477.1M | $847.7M | $910.5M | $606.5M | $1.5B | |
Short Term Investments | -- | -- | -- | -- | -- | |
Accounts Receivable, Net | $327.4M | $391.1M | $342.9M | $155M | $193.6M | |
Inventory | $36.8M | $36.2M | $54.1M | $76.5M | $72.5M | |
Prepaid Expenses | -- | -- | -- | -- | -- | |
Other Current Assets | -- | -- | -- | -- | -- | |
Total Current Assets | $1B | $1.4B | $1.4B | $932.2M | $1.9B | |
Property Plant And Equipment | $1.2B | $1.3B | $1.1B | $1.1B | $1.2B | |
Long-Term Investments | -- | -- | -- | -- | -- | |
Goodwill | $162.2M | $88.3M | $53.1M | $40.9M | $109M | |
Other Intangibles | $315.7M | $248.8M | $108.8M | $208.3M | $267.3M | |
Other Long-Term Assets | $100K | -$100K | $100K | -- | -- | |
Total Assets | $2.8B | $3.1B | $2.7B | $2.5B | $3.7B | |
Accounts Payable | $190.1M | $67.1M | $51.9M | $80.4M | $187.3M | |
Accrued Expenses | -- | -- | -- | -- | -- | |
Current Portion Of Long-Term Debt | -- | -- | -- | -- | -- | |
Current Portion Of Capital Lease Obligations | $3.8M | $15.7M | -- | $3.4M | $3.2M | |
Other Current Liabilities | -- | -- | -- | -- | -- | |
Total Current Liabilities | $311.6M | $399.5M | $400.1M | $270.8M | $731.6M | |
Long-Term Debt | $936M | $850M | $520.7M | $392.9M | $1.1B | |
Capital Leases | -- | -- | -- | -- | -- | |
Total Liabilities | $1.9B | $1.9B | $1.4B | $1.3B | $2.6B | |
Common Stock | $32.9M | $32.9M | $32.8M | $32.8M | $32.8M | |
Other Common Equity Adj | -- | -- | -- | -- | -- | |
Common Equity | -- | -- | -- | -- | -- | |
Total Preferred Equity | -- | -- | -- | -- | -- | |
Minority Interest, Total | -- | -- | -- | -- | -- | |
Total Equity | $905.7M | $1.1B | $1.4B | $1.2B | $1.1B | |
Total Liabilities and Equity | $2.8B | $3.1B | $2.7B | $2.5B | $3.7B | |
Cash and Short Terms | $477.1M | $847.7M | $910.5M | $606.5M | $1.5B | |
Total Debt | $936M | $858.9M | $555.7M | $427.9M | $1.4B |
Period Ending | 2020-12-31 | 2021-12-31 | 2022-12-31 | 2023-12-31 | 2024-12-31 | |
---|---|---|---|---|---|---|
Net Income to Stockholders | -$425.8M | $220.1M | $346.5M | $151.3M | -$13.3M | |
Depreciation & Amoritzation | $361.4M | $206M | $216.7M | $146.4M | $184.1M | |
Stock-Based Compensation | -- | -- | -- | -- | -- | |
Change in Accounts Receivable | $41.1M | -$99.5M | $59.9M | -$2.3M | -$46.1M | |
Change in Inventories | -$13.7M | $5M | -$11.2M | -$30.8M | $6M | |
Cash From Operations | $406.2M | $728.8M | $1.1B | $194.2M | $413M | |
Capital Expenditures | $225M | $280.6M | $374.8M | $283.3M | $371.8M | |
Cash Acquisitions | -- | -- | $17.3M | -$6.9M | -$9.4M | |
Cash From Investing | -$255.7M | -$362M | -$415M | -$281M | -$354.2M | |
Dividends Paid (Ex Special Dividend) | -- | -$22.2M | -$72.8M | -$92M | -$102.5M | |
Special Dividend Paid | ||||||
Long-Term Debt Issued | $152.3M | $400M | -- | -- | $365M | |
Long-Term Debt Repaid | -$290.3M | -$459M | -$323.7M | -- | -$131.2M | |
Repurchase of Common Stock | -$17.8M | -- | -$11.7M | -$50.7M | -- | |
Other Financing Activities | $100K | -- | -$100K | -- | -- | |
Cash From Financing | -$159.1M | -$105.4M | -$419.1M | -$147M | $123.2M | |
Beginning Cash (CF) | $485.7M | $477.1M | $736.6M | $954.3M | $718.8M | |
Foreign Exchange Rate Adjustment | -- | -- | -- | -- | -- | |
Additions / Reductions | -$8.6M | $261.4M | $222.2M | -$233.8M | $182M | |
Ending Cash (CF) | $477.1M | $736.6M | $954.3M | $718.8M | $899M | |
Levered Free Cash Flow | $181.2M | $448.2M | $681.5M | -$89.1M | $41.2M |
Period Ending | 2021-06-30 | 2022-06-30 | 2023-06-30 | 2024-06-30 | 2025-06-30 | |
---|---|---|---|---|---|---|
Net Income to Stockholders | $31.8M | $50M | -$15.7M | -$7.9M | -- | |
Depreciation & Amoritzation | $48.7M | $48.1M | $10.2M | $44.1M | -- | |
Stock-Based Compensation | -- | -- | -- | -- | -- | |
Change in Accounts Receivable | $2.2M | $45.1M | -$5.7M | -$18.4M | -- | |
Change in Inventories | $4.5M | -$4.2M | -$12.5M | $5.3M | -- | |
Cash From Operations | $172.6M | $300.4M | -$68.1M | $136.1M | -- | |
Capital Expenditures | $60.3M | $113.9M | $73.1M | $61.4M | -- | |
Cash Acquisitions | -- | -- | -$1.3M | -$64.3M | -- | |
Cash From Investing | -$92.9M | -$133.9M | -$76.2M | -$120.6M | -- | |
Dividends Paid (Ex Special Dividend) | -- | -- | -$22.1M | -$23M | -- | |
Special Dividend Paid | -- | -- | -- | -- | -- | |
Long-Term Debt Issued | -- | -- | -- | $350M | -- | |
Long-Term Debt Repaid | -$100M | -$203M | -- | -- | -- | |
Repurchase of Common Stock | -- | -- | -- | -- | -- | |
Other Financing Activities | -- | -$100K | -- | -$200K | -- | |
Cash From Financing | -$102.3M | -$205.7M | -$22.7M | $321M | -- | |
Beginning Cash (CF) | $477.1M | $847.7M | $910.5M | $606.5M | -- | |
Foreign Exchange Rate Adjustment | -$100K | -$7.8M | -$600K | $100K | -- | |
Additions / Reductions | -$22.6M | -$39.2M | -$167M | $336.5M | -- | |
Ending Cash (CF) | $454.2M | $800.6M | $742.9M | $943.1M | -- | |
Levered Free Cash Flow | $112.3M | $186.5M | -$141.2M | $74.7M | -- |
Period Ending | 2021-03-31 | 2022-03-31 | 2023-03-31 | 2024-03-31 | 2025-03-31 | |
---|---|---|---|---|---|---|
Net Income to Stockholders | -$329.2M | $381M | $297.3M | $52.4M | -$56.9M | |
Depreciation & Amoritzation | $306.9M | $204.5M | $209.8M | $151.6M | $185.4M | |
Stock-Based Compensation | -- | -- | -- | -- | -- | |
Change in Accounts Receivable | -$25.2M | -$23M | $75.6M | -$7.4M | -$93.9M | |
Change in Inventories | -$7.7M | -$400K | -$18M | -$22.3M | $6.9M | |
Cash From Operations | $391.4M | $912M | $915.9M | $181.9M | $408.9M | |
Capital Expenditures | $179.1M | $311.4M | $367.1M | $263.7M | $430.7M | |
Cash Acquisitions | -- | -- | $15.2M | -$8.1M | -$8.9M | |
Cash From Investing | -$205.1M | -$394.4M | -$391.4M | -$259.9M | -$413M | |
Dividends Paid (Ex Special Dividend) | -- | -$22.2M | -$75.2M | -$90.5M | -$106.8M | |
Special Dividend Paid | ||||||
Long-Term Debt Issued | $21.3M | -- | -- | -- | $995M | |
Long-Term Debt Repaid | -$270.3M | -$474.7M | -$308M | -$131.2M | -- | |
Repurchase of Common Stock | -- | -- | -$62.3M | -$100K | -- | |
Other Financing Activities | -- | -- | -- | -- | -- | |
Cash From Financing | -$252.7M | -$144.8M | -$456.2M | -$224.3M | $872.3M | |
Beginning Cash (CF) | -- | -- | -- | -- | -- | |
Foreign Exchange Rate Adjustment | -- | -- | -- | -- | -- | |
Additions / Reductions | -$66.4M | $372.8M | $68.3M | -$302.3M | $868.2M | |
Ending Cash (CF) | -- | -- | -- | -- | -- | |
Levered Free Cash Flow | $212.3M | $600.6M | $548.8M | -$81.8M | -$21.8M |
Period Ending | 2021-06-30 | 2022-06-30 | 2023-06-30 | 2024-06-30 | 2025-06-30 | |
---|---|---|---|---|---|---|
Net Income to Stockholders | $78.3M | $257.4M | $142.5M | $51.4M | $15.7M | |
Depreciation & Amoritzation | $101.7M | $99.6M | $54.8M | $93.9M | $51.1M | |
Stock-Based Compensation | -- | -- | -- | -- | -- | |
Change in Accounts Receivable | -$68.7M | $50.7M | $15.6M | -$2.2M | -$31.6M | |
Change in Inventories | $9.6M | -$4.5M | -$19.6M | $6.7M | $2.3M | |
Cash From Operations | $236.3M | $547.3M | $38.4M | $230.3M | $90.1M | |
Capital Expenditures | $111.1M | $195.5M | $147M | $115.7M | $113.2M | |
Cash Acquisitions | -- | -- | -$3.4M | -$67.6M | -$2.8M | |
Cash From Investing | -$155.7M | -$229.1M | -$147.8M | -$171.1M | -$109.3M | |
Dividends Paid (Ex Special Dividend) | -- | -$22.2M | -$46.7M | -$46.1M | -$27.4M | |
Special Dividend Paid | -- | -- | -- | -- | -- | |
Long-Term Debt Issued | -- | -- | -- | $350M | $630M | |
Long-Term Debt Repaid | -$100M | -$218.7M | -- | -$131.2M | -- | |
Repurchase of Common Stock | -- | -- | -$50.6M | -- | -- | |
Other Financing Activities | -- | -- | -- | -- | -- | |
Cash From Financing | -$103.4M | -$246.2M | -$100.3M | $166.1M | $594.2M | |
Beginning Cash (CF) | $954.2M | $1.6B | $1.9B | $1.3B | $899M | |
Foreign Exchange Rate Adjustment | $100K | -$7.8M | -$1.7M | -$1M | -$1.2M | |
Additions / Reductions | -$22.8M | $72M | -$209.7M | $225.3M | $575M | |
Ending Cash (CF) | $931.3M | $1.6B | $1.7B | $1.5B | $1.5B | |
Levered Free Cash Flow | $125.2M | $351.8M | -$108.6M | $114.6M | -$23.1M |
Signup to receive the latest stock alerts
GoodRX (NASDAQ:GDRX) tracks prescription drug prices and its model was…
Freeport-McMoRan (NYSE:FCX) is among the world’s largest producers of copper…
Levi Strauss (NYSE:LEVI) is among the oldest clothing brands in…
Market Cap: $4.2T
P/E Ratio: 58x
Market Cap: $3.8T
P/E Ratio: 43x
Market Cap: $3.1T
P/E Ratio: 35x
SharpLink Gaming [SBET] is down 2.6% over the past day.
Exodus Movement [EXOD] is down 4.14% over the past day.
Unity Software [U] is up 7.51% over the past day.